Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to PARABON NANOLABS, INC. in September, 2018 for $394,297.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AG062072-01 | Phase I | 394,297 | September 30, 2018 | |||||||
A SBIR Phase II contract was awarded to PARABON NANOLABS, INC. in September, 2021 for $1,186,625.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44AG062072-02A1 | Phase II | 1,186,625 | September 5, 2021 | |||||||
A SBIR Phase II contract was awarded to PARABON NANOLABS, INC. in September, 2018 for $993,513.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44AG050366-02A1 | Phase II | 993,513 | September 30, 2018 | |||||||
A STTR Phase I contract was awarded to PARABON NANOLABS, INC. in June, 2021 for $250,509.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41CA257001-01A1 | Phase I | 250,509 | June 1, 2021 | |||||||
A SBIR Phase I contract was awarded to PARABON NANOLABS, INC. in August, 2019 for $225,220.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI147831-01 | Phase I | 225,220 | August 8, 2019 | |||||||
A SBIR Phase II contract was awarded to PARABON NANOLABS, INC. in July, 2022 for $589,374.0 USD from the U.S. Department of Defense and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense. | SBIR | W911SR-22-C-0036 | Phase II | 589,374 | July 7, 2022 | |||||||
A SBIR Phase II contract was awarded to PARABON NANOLABS, INC. in January, 2022 for $708,981.0 USD from the U.S. Department of Defense and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense. | SBIR | W911SR-22-C-0002 | Phase II | 708,981 | January 20, 2022 | |||||||
A SBIR Phase II contract was awarded to PARABON NANOLABS, INC. in September, 2022 for $1,099,957.0 USD from the U.S. Department of Defense and Defense Threat Reduction Agency. | SBIR | HDTRA122C0031 | Phase II | 1,099,957 | September 7, 2022 | |||||||
A SBIR Phase II contract was awarded to PARABON NANOLABS, INC. in March, 2020 for $593,269.0 USD from the U.S. Department of Defense and United States Army. | SBIR | W911SR-20-C-0041 | Phase II | 593,269 | March 12, 2020 | |||||||
A SBIR Phase I contract was awarded to PARABON NANOLABS, INC. in March, 2021 for $167,458.0 USD from the U.S. Department of Defense and Defense Threat Reduction Agency. | SBIR | HDTRA121P0011 | Phase I | 167,458 | March 15, 2021 | |||||||
A SBIR Phase II contract was awarded to PARABON NANOLABS, INC. in October, 2018 for $999,996.51 USD from the U.S. Department of Defense and United States Army. | SBIR | W911SR-19-C-0026 | Phase II | 999,996.51 | October 16, 2018 | |||||||
A SBIR Phase I contract was awarded to PARABON NANOLABS, INC. for $599,999.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 75N93019C00012 | Phase I | 599,999 | ||||||||
A SBIR Phase I contract was awarded to PARABON NANOLABS, INC. in June, 2019 for $149,983.4 USD from the U.S. Department of Homeland Security. | SBIR | 70RSAT19C00000028 | Phase I | 149,983.4 | June 3, 2019 | |||||||
A SBIR Phase II contract was awarded to PARABON NANOLABS, INC. in March, 2016 for $999,931.0 USD from the U.S. Department of Defense. | SBIR | W911NF-16-C-0054 | Phase II | 999,931 | March 21, 2016 | |||||||
A SBIR Phase I contract was awarded to PARABON NANOLABS, INC. in September, 2014 for $149,999.0 USD from the U.S. Department of Defense. | SBIR | W911SR-14-C-0033 | Phase I | 149,999 | September 23, 2014 | |||||||
A SBIR Phase II contract was awarded to PARABON NANOLABS, INC. in January, 2015 for $999,970.0 USD from the U.S. Department of Defense. | SBIR | W911SR-14-C-0019 | Phase II | 999,970 | January 23, 2015 | |||||||
A SBIR Phase II contract was awarded to PARABON NANOLABS, INC. in February, 2017 for $999,999.15 USD from the U.S. Department of Defense. | SBIR | W911SR-17-C-0010 | Phase II | 999,999.15 | February 15, 2017 | |||||||
A SBIR Phase I contract was awarded to PARABON NANOLABS, INC. in December, 2012 for $150,000.0 USD from the U.S. Department of Defense. | SBIR | W911SR-13-C-0019 | Phase I | 150,000 | December 6, 2012 | |||||||
A SBIR Phase II contract was awarded to PARABON NANOLABS, INC. in May, 2013 for $749,918.0 USD from the U.S. Department of Defense. | SBIR | W911NF-13-C-0044 | Phase II | 749,918 | May 21, 2013 | |||||||
A SBIR Phase I contract was awarded to PARABON NANOLABS, INC. in June, 2015 for $179,819.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AG050366-01 | Phase I | 179,819 | June 15, 2015 | |||||||
A STTR Phase II contract was awarded to PARABON NANOLABS, INC. in February, 2013 for $465,948.0 USD from the U.S. Department of Defense. | STTR | W911NF-13-C-0016 | Phase II | 465,948 | February 20, 2013 | |||||||
A SBIR Phase II contract was awarded to PARABON NANOLABS, INC. in July, 2017 for $999,999.2 USD from the U.S. Department of Defense. | SBIR | W911SR-17-C-0046 | Phase II | 999,999.2 | July 31, 2017 | |||||||
A STTR Phase I contract was awarded to PARABON NANOLABS, INC. in April, 2016 for $230,000.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41AI118522-01A1 | Phase I | 230,000 | April 1, 2016 | |||||||
A SBIR Phase I contract was awarded to PARABON NANOLABS, INC. in September, 2011 for $150,000.0 USD from the U.S. Department of Defense. | SBIR | W911NF-11-C-0267 | Phase I | 150,000 | September 26, 2011 | |||||||
A STTR Phase I contract was awarded to PARABON NANOLABS, INC. in April, 2011 for $100,000.0 USD from the U.S. Department of Defense. | STTR | W911NF-11-C-0076 | Phase I | 100,000 | April 11, 2011 |